Common osteoporosis drugs linked to 24% lower dementia risk in major study
60-Word AI Digest
A massive study of more than 120,000 older adults suggests that common osteoporosis drugs may reduce the risk of Alzheimer’s disease and other dementias by up to 24%. The surprising findings raise the possibility that medications already used to strengthen bones could also help protect the aging brain.
Key Takeaways
- A massive study of more than 120,000 older adults suggests that common osteoporosis drugs may reduce the risk of Alzheimer’s disease and other dementias by up to 24%.
- The surprising findings raise the possibility that medications already used to strengthen bones could also help protect the aging brain.
- Full details and original dispatch available below.
A massive study of more than 120,000 older adults suggests that common osteoporosis drugs may reduce the risk of Alzheimer’s disease and other dementias by up to 24%. The surprising findings raise the possibility that medications already used to strengthen bones could also help protect the aging brain.
Original Publisher Attribution
This summary was curated from ScienceDaily.